Cyclerion Therapeutics, Inc. (CYCN)
NASDAQ: CYCN · Real-Time Price · USD
2.090
+0.330 (18.75%)
At close: Nov 20, 2024, 4:00 PM
2.020
-0.070 (-3.35%)
After-hours: Nov 20, 2024, 6:44 PM EST
Cyclerion Therapeutics Employees
Cyclerion Therapeutics had 1 employees as of December 31, 2023. The number of employees decreased by 15 or -93.75% compared to the previous year.
Employees
1
Change (1Y)
-15
Growth (1Y)
-93.75%
Revenue / Employee
$194,000
Profits / Employee
-$5,281,000
Market Cap
5.26M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Kindly MD | 65 |
Biomerica | 64 |
Applied DNA Sciences | 55 |
Aptevo Therapeutics | 40 |
Organovo Holdings | 20 |
Purple Biotech | 20 |
Windtree Therapeutics | 20 |
Aethlon Medical | 14 |
CYCN News
- 3 months ago - Regina Graul, Ph.D., Promoted to Chief Executive Officer - GlobeNewsWire
- 1 year ago - Cyclerion Appoints Regina Graul, Ph.D., as President - GlobeNewsWire
- 1 year ago - Cyclerion Strengthens Board of Directors with Experienced Company Builder and Cutting-edge Innovator - GlobeNewsWire
- 1 year ago - Tisento Launches with $81 Million From Top-Tier Investor Syndicate and Promising Cyclerion Assets - GlobeNewsWire
- 1 year ago - Cyclerion Regains Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewsWire
- 1 year ago - Cyclerion Announces Reverse Stock Split - GlobeNewsWire
- 1 year ago - Cyclerion Announces Definitive Agreement for Zagociguat and CY3018 - GlobeNewsWire
- 1 year ago - Cyclerion Announces Corporate Updates and Q1 2023 Financial Results - GlobeNewsWire